CAS: 1569-16-0; 2-Methyl[1,8]-Naphthyridine

相似化合物

14903-78-7 64379-45-9 14757-45-0

上下游产品

CAS号1824-81-3 2-氨基-6-甲基吡啶 | CAS号127-68-4 间硝基苯磺酸钠 | CAS号2802-08-6 1-二甲基呋喃-1-3-酮 | CAS号86847-59-8 2-特戊酰胺基吡啶 | CAS号504-29-0 2-氨基吡啶 | CAS号77972-44-2 1,7-dimethyl-1,... | CAS号445492-19-3 1-N-叔丁氧羰基-3,4-二... | CAS号274676-47-0 7-甲基-1,2,3,4-四氢... | CAS号64379-45-9 [1,8]萘啶-2-甲醛 | CAS号339536-82-2 Ethyl 1,8-napht... | CAS号125902-27-4 (1,8-萘啶-2-基)甲醇 | CAS号125902-26-3 1,8-萘啶-2-羧酸甲酯 | CAS号125902-24-1 2-(trichloromet... | CAS号14903-78-7 2, 7-二甲基-1, 8-萘啶 | CAS号215523-34-5 1,8-萘啶-2-甲酸

2-(特戊酰氨基)吡啶-3-醛置于盐酸,Potassium Hydroxide体系中,用 甲醇,水 用作溶剂,化学反应生成2-甲基-[1,8]-萘啶
参考文献:具有 1,8-萘啶基双(甲硅烷基)支撑配体的二钌配合物:含有 Ruii2(μ-H)2 和 Rui2 核的配合物的合成和结构
标题:具有 1,8-萘啶基双(甲硅烷基)支撑配体的二钌配合物:含有 Ruii2(μ-H)2 和 Rui2 核的配合物的合成和结构
摘要:我们设计了一种新型的基于萘啶的支持配体,它涉及 2,7 位的两个甲硅烷基配位部分,T-Bunbsi,用于合成双核金属配合物.配体前体 T-Bunbsi(H)2 (1) 与 Ru3(Co)12 反应得到二-μ-氢化二钌 (Ii,Ii) 配合物 (T-Bunbsi)Ru2(μ-H)2(Co)4 (2). 光照射 2 导致形成二钌 (I,I) 络合物 (T-Bunbsi)Ru2(Co)6 (3).2 的 Si-Ru-Ru-Si 连接采用锯齿形排列,而 3 的连接采用大致线性的排列.
Doi:10.1246/cl.171099

专利信息

专利号:WO-2005051904-A2
优先权日:2003-10-23
标题 :Novel processes for the synthesis of cyclopropyl compounds

专利号:US-9670230-B2
优先权日:2012-11-29
标题 :Heteroaryl compounds and methods of use thereof
发明人：CAMPBELL JOHN EMMERSON; JONES PHILIP
权利人:SUNOVION PHARMACEUTICALS INC
摘要:Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes.

专利号:US-2008187575-A1
优先权日:2004-08-27
标题:Pyrimidine Derivatives
发明人：KLEBL BERT; BAUMANN MATTHIAS; HOPPE EDMUND; BREHMER DIRK; DAUB HENRIK; KERI GYORGY; VARGA ZOLTAN; MAROSFALVI JENO; ORFI LASZLO
权利人:KLEBL BERT; BAUMANN MATTHIAS; HOPPE EDMUND; BREHMER DIRK; DAUB HENRIK; KERI GYORGY; VARGA ZOLTAN; MAROSFALVI JENO; ORFI LASZLO
摘要:The present invention relates to pyrimidine derivatives, methods for their synthesis, and the use of said pyrimidine derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferation disorders, cancer, leukemia, erectile dysfunction, cardiovascular diseases and disorders, inflammatory diseases, transplant rejection, immunological diseases, neuroimmunological diseases, autoimmune diseases, infective diseases including opportunistic infections, prion diseases and/or neuro-degeneration. Furthermore, the present invention relates to pharmaceutical compositions containing at least one pyrimidine derivative and/or pharmaceutically acceptable salts thereof as an active ingredient together with at least one pharmaceutically acceptable carrier, excipient or diluents as well as to methods for prophylaxis and/or treatment of the above-mentioned diseases and disorders.